Domainex
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Chesterford Research Park Little Chester...Phone Number
+44 1223433180Website
www.domainex.co.ukRevenue
$28.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Domainex
Domainex is a leading integrated medicines research service partner working with ambitious life science organisations from around the globe. The company has been setting new standards in research since 2001, working collaboratively with pharmaceutical and biotechnology companies, patient foundations and leading academic institutions. The company provides innovative and customised assay and structural biology combined with computational, synthetic, medicinal and analytical chemistry services to advance the disease research projects of the company's partners, from target expression to pre-clinical development candidate nomination. Working with Domainex maximises the chance of successful progression for the company's partners' research and the company's approach consistently saves up to 30% of the time needed to discover new medicines by comparison with the industry average. The company's innovative science and extensive technical capabilities enable the company to produce novel medicinesRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Domainex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Domainex had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Domainex has new funding data
Check out if Domainex is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Domainex
Check if Domainex has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Domainex recently announced quarterly report
Product Launch: Get notified when Domainex launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Domainex, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Domainex as Masked Content
Find 2 more new buyers
Compare Similar Companies to Domainex
Compare insights from companies similar to Domainex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Domainex
$28.3M
51-200
Private
-
2001
N/A
Company Profile Activity
Activity Insights
Domainex is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Domainex is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Domainex.
Domainex Tech Stack
A closer look at the technologies used by Domainex
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Open Position
Event
Events
Domainex News & Media
Nuclera’s eProtein Discovery System Installed at Domainex to Streamline Protein Production Services
CAMBRIDGE, England--(BUSINESS WIRE)--Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award winning provider of integrated, pre-clinical drug discovery services, today announced that Domainex is the first contract research organization (CRO) to have installed the eProtein Discovery system and offer protein production services using the technology. Domainex provides a complete range of pre-cDomainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform
Wädenswil/Zurich, Switzerland, and Saffron Walden, UK, 12 January 2021 – Domainex Ltd. (https://www.domainex.co.uk/), a leading provider of integrated drug discovery services, is pleased to announce that it has invested in the WAVEdelta instrument from Creoptix AG (https://www.creoptix.com/). This instrument utilizes Grating-Coupled Interferometry (https://www.domainex.co.uk/services/biophysics/surface-plasmon-resonance-SPR-and-GCI) (GCI) to measure target binding on sensor chips, generating binInvivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia
SAN DIEGO and SAFFRON WALDEN, United Kingdom, July 14, 2020 /PRNewswire/ -- Invivoscribe, Inc., an industry pioneer and global leader in the field of precision diagnostics announces the launch of a fully integrated drug development engine. This new engine will combine with its in-house expertise in diagnostics development and worldwide access to patients and clinical testing capabilities to accelerate drug development. Invivoscribe's therapeutics division also announced today that th
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Domainex
Sign Up For FreeTo access detailed company insights
Domainex is a leading integrated medicines research service partner working with ambitious life science organisations from around the globe. The company has been setting new standards in research since 2001, working collaboratively with pharmaceutical and biotechnology companies, patient foundations and leading academic institutions. The company pr... Read More
